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Abstract
Background: Clinically, a distinction is made between types of rotator cuff tear, traumatic and non-traumatic, and
this sub-classification currently informs the treatment pathway. It is currently recommended that patients with
traumatic rotator cuff tears are fast tracked for surgical opinion. However, there is uncertainty about the most
clinically and cost-effective intervention for patients with traumatic rotator cuff tears and further research is
required.
SPeEDy will assess the feasibility of a fully powered, multi-centre randomised controlled trial (RCT) to test the
hypothesis that, compared to surgical repair (and usual post-operative rehabilitation), a programme of
physiotherapist-led exercise is not clinically inferior, but is more cost-effective for patients with traumatic rotator cuff
tears.
Methods: SPeEDy is a two-arm, multi-centre pilot and feasibility RCT with integrated Quintet Recruitment
Intervention (QRI) and further qualitative investigation of patient experience. A total of 76 patients with traumatic
rotator cuff tears will be recruited from approximately eight UK NHS hospitals and randomly allocated to either
surgical repair and usual post-operative rehabilitation or a programme of physiotherapist-led exercise. The QRI is a
mixed-methods approach that includes data collection and analysis of screening logs, audio recordings of
recruitment consultations, interviews with patients and clinicians involved in recruitment, and review of study
documentation as a basis for developing action plans to address identified difficulties whilst recruitment to the RCT
is underway. A further sample of patient participants will be purposively sampled from both intervention groups
and interviewed to explore reasons for initial participation, treatment acceptability, reasons for non-completion of
treatment, where relevant, and any reasons for treatment crossover.
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Discussion: Research to date suggests that there is uncertainty regarding the most clinically and cost-effective
interventions for patients with traumatic rotator cuff tears. There is a clear need for a high-quality, fully powered,
RCT to better inform clinical practice. Prior to this, we first need to undertake a pilot and feasibility RCT to address
current uncertainties about recruitment, retention and number of and reasons for treatment crossover.
Trial registration: ClinicalTrials.gov (NCT04027205) – Registered on 19 July 2019. Available via
Keywords: Surgery, Physiotherapy, Exercise, Rotator cuff tear, Shoulder, Randomised controlled trial
Introduction
Background and rationale
Shoulder pain presents a significant personal, social and
economic burden and impacts on work, ability to under-
take leisure and household tasks and causes disturbed
sleep [1]. Tears of the rotator cuff are regarded as a sig-
nificant cause of shoulder pain and rates of surgery to
repair the torn rotator cuff have risen approximately
200% over recent years across Europe and the USA [2–
5]. In the UK NHS, 8838 surgical repairs of the rotator
cuff were undertaken in 2018/2019 with approximately
one-third undertaken for traumatic tears [6]. Depending
on complexity, the cost of surgical repair ranges from
£3676 to £6419 [7] meaning that direct NHS treatment
costs alone range from £26.6 to £51.4 million annually,
and £10.8 to £18.9 million specifically for traumatic rota-
tor cuff tears.
Different treatment pathways are proposed in the
current British Elbow & Shoulder Society and British
Orthopaedic Association guidelines [8] for patients pre-
senting with non-traumatic as opposed to traumatic ro-
tator cuff tears. These guidelines recommend that
patients with traumatic rotator cuff tears are fast tracked
for surgical opinion. Three randomised controlled trials
(RCTs) (n = 252) comparing surgery to non-surgical
treatment for rotator cuff tears have been undertaken
and synthesised in a systematic review (SR) [9]. The re-
view concluded that, although the evidence is limited in
terms of quality, current research suggests no difference
in clinical outcomes at 1 year between surgery and non-
surgical treatment. However, of the 252 patients in-
cluded in the SR, only 40 (16%) were diagnosed with
traumatic tears of the rotator cuff (24 randomised to
surgery; 16 to physiotherapist-led exercise). Since the
publication of this SR, one further RCT (n = 58) focusing
specifically on traumatic rotator cuff tears has been pub-
lished [10]. This RCT compared surgical repair with a
programme of physiotherapist-led exercise for acute
traumatic rotator cuff tears located mainly within
supraspinatus [10]. At 12 months, there was no signifi-
cant between-group difference in terms of shoulder pain
and function. Re-tear was reported in 6.5% of partici-
pants undergoing repair and tear size progression
greater than 5 mm in 29.2% of participants undergoing
the programme of physiotherapist-led exercise [10].
Hence, there is uncertainty about optimal interventions
for traumatic rotator cuff tears based on evidence from a
limited number of patients and from RCTs with rela-
tively short-term follow-up.
Despite this uncertainty from RCTs, other reasons for
current guidelines recommending fast track for surgical
opinion for people with traumatic rotator cuff tears in-
clude a concern that a delayed surgical repair is more
technically challenging and that delay risks poorer clin-
ical outcomes. Several non-randomised studies have
evaluated the impact of time to surgery on clinical out-
comes. Findings vary considerably with some recom-
mending surgery within 4 months of symptom onset
[11], some 6months [12] and some 24 months [13], yet
others conclude that time to surgery is not a critical fac-
tor [14]. Thus, there is considerable uncertainty and
given that asymptomatic rotator cuff tears are very com-
mon, it is also difficult to attribute tears of the rotator
cuff to recent trauma with confidence [15]. Imaging for
shoulder pain following trauma may in fact be identify-
ing an existing asymptomatic rotator cuff tear. Another
reason proposed in support of current guidelines recom-
mending fast track for surgical opinion relates to pro-
gression, i.e. the increasing size of a rotator cuff tear if
not operated on [16]. It has been reported that 42 to
47% of symptomatic tears increase in size up to 100
months follow-up [16, 17] with the greatest rate of in-
crease in those with full-thickness tears observed in 82%
versus 26% of those with partial-thickness tears [17].
Hence, most full thickness and some partial-thickness
rotator cuff tears do increase in size over time, but it is
apparent that some do not and, importantly, surgery is
not guaranteed to prevent progression and these in-
creases in the size of tear are not consistently associated
with poorer clinical outcome in terms of pain and func-
tion [17, 18]. To further highlight uncertainty in the
management of rotator cuff tears, the UKUFF trial [1]
reported a 40% re-tear or failed-healing rate following
surgical repair of non-traumatic rotator cuff tears but
the outcomes for these patients were not clinically sig-
nificantly different from those patients who did not re-
tear their rotator cuff. Similar findings have also been re-
ported in a systematic review and meta-analysis of 14
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studies (n = 861) [19]. This suggests that the tear might
not be the only source of symptoms and surgical repair,
in some circumstances, might be unwarranted. In situa-
tions where both the source of symptoms and the mech-
anism of action of surgery are questioned, a
physiotherapist-led exercise might be a credible treat-
ment option just as it currently is for patients with non-
traumatic tears [20].
The above uncertainty and lack of evidence to inform
decision-making provides the justification for the
current research study.
Objectives
The aim of the SPeEDy study is to determine if it is feas-
ible to conduct a future, substantive, multi-site RCT to
test the hypothesis that physiotherapist-led exercise is
not inferior to surgical repair of the rotator cuff in terms
of clinical outcomes but is more cost-effective.
The following objectives are to:
1) Determine feasibility of recruiting patients
2) Determine feasibility of retaining participants,
including response rates to questionnaires
3) Determine zone of clinical equipoise, including
exploration of what patient characteristics (age, size,
and location of rotator cuff tear etc.) influence
whether clinicians are prepared to randomise
patients or not
4) Determine proportion and reasons for treatment
crossover
5) Estimate the number of potential and willing sites
for the future main RCT
6) Identify barriers and facilitators to recruitment and
retention
7) Determine participant satisfaction with the
interventions
8) Determine the number and nature of adverse events
Trial design
The SPeEDy study is a two-arm, multi-centre pilot and
feasibility RCT (1:1 allocation ratio) with integrated
Quintet Recruitment Intervention (QRI) and further
qualitative investigation of patient experience (Figs. 1
and 2).
Methods: Participants, interventions and
outcomes
Study setting
Patients will be recruited from orthopaedic departments
of the participating UK NHS hospitals. The study inter-
ventions will be delivered through their associated
orthopaedic and physiotherapy services.
Eligibility criteria
Inclusion criteria
1) Adult patients (≥ 18 years)
2) Diagnosed with a symptomatic tear of the rotator
cuff following a traumatic incident thought to be of
sufficient force to induce a tear
3) Rotator cuff tear confirmed by diagnostic
ultrasound or MRI scan undertaken as part of
routine diagnostic workup
4) Eligible for rotator cuff repair surgery or a
programme of physiotherapist-led exercise as deter-
mined by the attending clinician (surgeon or
physiotherapist, where appropriate)
5) Able to return to the participating NHS hospital or
associated orthopaedic and physiotherapy services
(where physiotherapists have been trained in trial
interventions) for post-operative rehabilitation or
the programme of physiotherapist-led exercise
6) Able to understand English
Exclusion criteria
1) Not eligible for rotator cuff repair surgery or a
programme of physiotherapist-led exercise as deter-
mined by the attending clinician (surgeon or
physiotherapist, where appropriate)
2) Patients who are unable to give full informed
consent
Who will take informed consent?
A local clinician or local research healthcare practi-
tioner, who will have received appropriate training and
is authorised on the trial delegation log, will support the
process of informed consent. Interested and eligible pa-
tients will be required to provide written informed con-
sent before participating (see reference below to optional
Quintet Recruitment Intervention (QRI) and optional 6-
month qualitative interviews). Written informed consent
for the QRI will be sought at the time of attendance at
the orthopaedic clinic. Consent for the RCT will be
sought at the time of attendance at the orthopaedic
clinic or other convenient time prior to the surgery if
the patient requests more time to consider participation.
The RCT consent form indicates if the participant
would like to be contacted for the purpose of the 6-month
qualitative interviews. If the participant indicates yes, a re-
searcher will contact the participant and if they agree to
take part, a subsequent consent form will be signed.
Interventions
Explanation for the choice of comparators
Fast track for surgical opinion and surgical repair of the
traumatic rotator cuff tear is the current standard of care
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and this will be compared with a programme of
physiotherapist-led exercise, should this prove feasible
during this pilot phase, testing the hypothesis that the
latter is not clinically inferior to the standard of care but
is more cost-effective.
Intervention description
Surgical repair plus usual post-operative rehabilitation
Surgical repair will be guided by the size and location of
the tear and also surgeon preference, the details of which
will be recorded on a specific case report form and re-
ported accordingly. Similarly, the content of post-
operative rehabilitation is variable across the UK but
typically begins with a period of immobilisation using an
arm sling for up to 6 weeks. After this period,
rehabilitation progresses gradually with the aim of re-
storing movement, strength and function [22].
Structured and progressive physiotherapist-led
exercise programme The exercise programme is based
on the principle of self-dosing with the aim of restoring
functional capacity to a level acceptable to the indi-
vidual participant. Exercise prescription is based on
establishing the current functional capacity of the
patient in relation to the most challenging shoulder
movements and is supported over approximately six
contact sessions with a physiotherapist across a 12-
week period. The development process and resultant
programme of physiotherapist-led exercise used in
the SPeEDy study has been reported elsewhere in
full [23].
Fig. 1 Study flow chart
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Criteria for discontinuing or modifying allocated
interventions
There are no special criteria for discontinuing or modi-
fying allocated interventions.
Participants may choose to withdraw from the allo-
cated intervention for any reason and continue a plan of
treatment determined in consultation with their attend-
ing clinician.
Strategies to improve adherence to interventions
Adherence to the physiotherapist-led exercise programme
will be recorded in an exercise diary provided to the pa-
tient and monitored by the physiotherapist. No further
strategies beyond usual encouragement will be used.
Relevant concomitant care permitted or prohibited during
the trial
No special provisions.
Provisions for post-trial care
None beyond standard care within the NHS.
Outcomes
Feasibility outcomes
1) Numbers of patients screened, number eligible,
number approached, number consenting, number
randomised and number accepting allocation and
reasons for patients not being eligible, approached
or declining participation
Fig. 2 Schedule of enrolment, interventions and assessments (SPIRIT Statement) [21]
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2) Numbers of participants receiving and completing
the allocated intervention
3) Follow-up response rates to questionnaires at 3 and
6 months post-randomisation (including Oxford
Shoulder Score and EQ-5D-5L)
4) Determine reasons for not approaching potentially
eligible patients and how this varies between clinicians
5) Numbers of participants receiving intervention
(surgery or PT-led exercise) other than that which
was allocated to determine proportion of partici-
pants who crossover
6) Numbers of sites agreeing to participate and
numbers of additional sites who are interested in
participating in the main trial
7) Participant satisfaction with the interventions on a
five-point ordinal scale; very satisfied/satisfied/neu-
tral/dissatisfied/very dissatisfied
8) Barriers and facilitators to recruitment, retention
and treatment crossover (qualitative data; audio
recording and individual interviews)
Clinical outcomes
1) Pain and disability assessed using the Oxford
Shoulder Score (OSS) at baseline, 3 and 6 months
post-randomisation by post with telephone call for
minimum data collection if no response to reminder
postal questionnaire
2) Health-related quality of life assessed using the EQ-
5D-5L at baseline, 3 and 6 months post-
randomisation by post with telephone call for mini-
mum data collection if no response to reminder
postal questionnaire
3) Days lost from work due to the shoulder problem
at 3 and 6 months post-randomisation via postal
questionnaire
4) Time taken to return to driving, if applicable, via
questionnaire at 3 and 6 months post-
randomisation via postal questionnaire
5) Number and type of adverse events for up to 6
months post-randomisation via patient self-report
questionnaire or telephone Minimal Data Collection
(MDC) at 3 and 6 months and via surgeon, physio-
therapist or GP report
Self-report data relating to further healthcare resource
use, including NHS- and private-borne service, and
medication costs will also be collected.
Participant timeline
See s. 1 and 2.
Sample size
Randomising 76 participants will enable the 1-sided
lower 90% confidence limit for the follow-up rate to be
estimated within about 6% of the anticipated 80% level
at 6 months. Further, a sample size of about 76, allowing
for dropout, will be sufficient to allow precise calculation
of estimates of standard deviation around the OSS for
the main RCT [24].
Additionally, with reference to treatment crossover of
less than 25% (principal concern relates to those rando-
mised to the physiotherapist-led exercise programme
crossing over to surgery), randomising 38 participants to
the physiotherapist-led exercise programme enables pre-
cise 1-sided upper confidence limits (e.g. around 8%
above the desired upper level of around 15% for a 90%
upper confidence limit).
Recruitment
Potential participants will be identified when the diagno-
sis of symptomatic traumatic rotator cuff tear is made
(sudden onset of shoulder pain and weakness following
a traumatic incident with a tear confirmed by ultrasound
or MRI) and surgery is considered a treatment option.
The patient pathway is variable between sites but, typic-
ally, this diagnosis and identification of the two possible
management options will be made by an orthopaedic
surgeon, or physiotherapist, who will subsequently intro-
duce the RCT to the patient. If the patient expresses
interest, further discussion will ensue between the pa-
tient and the clinician or research healthcare practitioner
(depending on availability) who will provide them with a
study information pack, by hand or in the post, and fol-
low this up with a discussion, face-to-face or over the
telephone.
Assignment of interventions: Allocation
Sequence generation
Participants will be allocated on a 1:1 ratio, stratified by
tear size (large tear ≥ 3 cm/small to medium sized tear <
3 cm/or not known), using mixed-block randomisation.
Concealment mechanism
Randomisation will be undertaken remotely using web-
based randomisation to ensure allocation concealment
provided by Derby Clinical Trials Support Unit.
Implementation
The participant will be informed of the allocation by the
clinician or research healthcare practitioner, depending
on availability, and will then access the interventions as
per usual treatment pathways, including being placed on
a waiting list for surgery or physiotherapy.
Assignment of interventions: Blinding
Who will be blinded
No measures to blind participants, clinicians, research
team or oversight committees will be implemented.
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Data collection and management
Plans for assessment and collection of outcomes
Local sites will complete screening logs and participants
will complete the baseline questionnaire, including
demographic data, the Oxford Shoulder Score (OSS) and
EQ-5D-5L. The OSS is a 12-item shoulder-specific self-
report measure of shoulder pain and function primarily
for the assessment of outcome of shoulder surgery in
RCTs [25]. The OSS is reliable, valid, responsive and ac-
ceptable to patients [1, 25, 26]. The items refer to the
past 4 weeks with five ordinal response options scored
from 0 to four, with four representing the best outcome.
When the 12 items are summed, this produces an over-
all score ranging from 0 to 48, with 48 being the best
outcome.
The EQ-5D-5L is a generic measure of health-related
quality of life that provides a single index value for
health status that can be used for the purpose of clinical
and health economic evaluation [27]. The EQ-5D-5L
consists of questions relating to five health domains
(mobility, self-care, usual activities, pain/discomfort,
anxiety/depression), and respondents rate their degree of
impairment using five response levels (no problems,
slight problems, moderate problems, severe problems
and extreme problems) [27]. EQ-5D is the National In-
stitute for Health and Care Excellence’s (NICE) pre-
ferred measure of health-related quality of life in adults.
Follow-up at 3 and 6months post-randomisation will
be via postal questionnaire.
Plans to promote participant retention and complete
follow-up
Follow-up processes include reminders and MDC via
telephone if questionnaires are not returned within 2
and 4 weeks respectively.
Data management
All participants are given an individual study number
that will be used on all case report forms for that partici-
pant. Case report forms will be processed and stored
securely.
Confidentiality
All collected information will be kept strictly confiden-
tial and will be stored in accordance with the General
Data Protection Regulations (GDPR) and retained in ac-
cordance with the latest Directive on Good Clinical
Practice (GCP) and local policy.
Statistical methods
Statistical methods for primary and secondary outcomes
As this is a pilot and feasibility RCT, the main analysis
will focus on process outcomes, including consent rate,
retention rate and follow-up rates. Means and
confidence intervals of the OSS will be calculated in
order to inform the sample size calculation for the main
RCT. Analysis will be undertaken using the IBM SPSS
statistics package (https://www.ibm.com/uk-en/prod-
ucts/spss-statistics). A detailed data analysis plan will be
agreed with the independent trial steering committee
(TSC) before any analysis is undertaken.
The following success criteria will be used to decide
on whether to proceed to developing a main RCT:
i) Identification of eight recruiting sites during the
pilot phase with expressions of interest from at least
a further eight sites
ii) Recruitment rates: Consent and randomisation of
20% or more of eligible patients
iii) Treatment crossover less than 25%, of those
randomised, at 6 months in each of the two
treatment groups
iv) Follow-up rates for the OSS greater than 70% at 6
months
Interim analyses
No interim analyses are planned.
Methods for additional analyses (e.g. subgroup analyses)
No additional analyses are planned.
Methods in analysis to handle protocol non-adherence and
any statistical methods to handle missing data
The primary analysis will be intention to treat. However,
an additional per-protocol analysis will be undertaken to
account for any participants who did not receive the al-
located intervention within the study period, with no ac-
count taken of protocol non-adherence beyond
reporting of treatment crossover.
The Quintet recruitment intervention
RCTs can be challenging to recruit to, with clear obsta-
cles including a lack of time and strong patient prefer-
ences, but also hidden challenges including tensions for
clinicians and challenges around assuming a position of
equipoise [28, 29]. However, without systematic evalu-
ation, hidden challenges remain unknown and opportun-
ities to change RCT processes, for example, study
training and documentation, are lost to the potential
detriment to the RCT. In recognition of this, the QRI
will be integrated within the SPeEDy RCT to understand
the challenges associated with recruitment and develop
action plans to address these challenges rapidly whilst
recruitment is underway.
The QRI is a mixed-methods approach that includes
data collection and analysis of screening and eligibility
logs, audio recordings of recruitment consultations (i.e.
consultations during which recruitment to the RCT is
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discussed), individual interviews with patients and clini-
cians involved in recruitment, and review of study docu-
mentation as a basis for developing action plans to
address identified difficulties whilst recruitment to the
RCT is underway [30, 31]. It has been shown to facilitate
recruitment to the most challenging RCTs, including
orthopaedic RCTs [29, 32]. A targeted QRI, investigating
recruiter information provision, patient responses to this
information and recruitment performance across re-
cruiters/sites, will be integrated within the SPeEDy RCT
over the recruitment period to enable barriers to recruit-
ment to be identified and any changes to the recruit-
ment process to be made and re-evaluated.
In line with the SEAR (Screening, Eligibility,
Approached, Randomised) framework [33], screening
and eligibility logs will detail all patients screened (by
the research healthcare practitioner (RHCP) and attend-
ing clinician) to identify how many are eligible,
approached, accepting randomisation and the allocated
intervention, alongside reasons not eligible, approached
or accepting randomisation. These will be completed at
the clinical site.
Clinic and recruitment appointments involving discus-
sion of the SPeEDy RCT will be audio recorded and then
subjected to targeted data extraction and transcription,
focusing analysis on discussion of issues relevant to re-
cruitment to the SPeEDy RCT, to investigate how re-
cruiters present the study to patients and how patients
respond.
In-depth, semi-structured interviews will be con-
ducted, guided by topic guides with a purposive sample
of patients and clinicians involved in identifying patients
and RHCPs (responsible for explaining the trial and
obtaining informed consent) from selected sites. Selec-
tion of sites will be determined by willingness to partici-
pate in the QRI and determined by relative recruitment
performance, i.e. high and low-recruiting sites.
Given the responsive and iterative nature of the QRI,
it is not realistic to pre-specify a required number of
participants. But, we will aim to sample data from four
out of the eight-hospital sites including six to 12 clini-
cians and 12‑20 patients or until saturation is reached.
Data collection will be limited to the pre-specified max-
imum 9-month period. However, data collection will
cease if no new themes emerge from the ongoing ana-
lysis prior to this time point.
Data from the screening and eligibility logs will be
analysed descriptively to identify differences between
sites and points in the recruitment pathway where pa-
tients at particular sites are ‘lost’ to recruitment. Find-
ings from this analysis will guide sampling for audio
recording of recruitment discussions and interviews.
Audio recordings of clinic and recruitment appoint-
ments will be analysed using thematic, content and
targeted conversation analysis techniques with the aim
of understanding the challenges to recruitment [34]. In
tandem with this, data from individual interviews will be
analysed using constant comparison techniques which
involves detailed coding followed by comparison of
emerging themes and codes within transcripts and
across the dataset looking for shared or disparate views.
Findings will be presented anonymously.
Study documentation, including PIS and consent
forms and Trial Management Group (TMG)/Trial Steer-
ing Committee (TSC) meeting minutes, will be reviewed
with reference to the findings from the interviews and
recruitment appointments. Data from screening logs,
audio recordings, interviews and study documentation
will be triangulated to identify where findings are con-
firmed across data sources.
Upon completion of this analysis, an action plan will
be generated to address factors that appear to be hinder-
ing recruitment. Previous reports of the outcome of the
QRI have identified generic and study-specific barriers
to recruitment which can be addressed through bespoke
action plans [29]. Also in some instances, the QRI has
provided clear reasons why recruitment to the RCT
might not be achievable [29]. Once the action plan is
agreed, where relevant, study documentation will be
amended and further training offered to recruiters across
all of the hospital sites. Post-implementation of the plan,
a further evaluation of the recruitment process will be
undertaken using feasibility outcome data described in
this protocol.
Patient experience of trial participation
Following the 6-month follow-up point, a further sample
of patient participants will be purposively sampled from
both intervention groups and interviewed to explore rea-
sons for initial participation, treatment acceptability, rea-
sons for non-completion of treatment, where relevant,
and any reasons for treatment crossover.
Patients will be purposefully sampled with respect to
allocated group, change in pain and disability status ac-
cording to the OSS, whether the allocated treatment was
completed or not and in relation to treatment crossover.
Patients will be able to decline participation in the inter-
views yet still be involved in the RCT.
The interviews will be based not only on semi-
structured topic guides developed in relation to the pre-
specified aims but also with our patient and public in-
volvement group (approximately 30-min telephone
interview). It is expected that approximately 20 patients
will be sufficient to attain rich data. Telephone inter-
views will be conducted, audio recorded and transcribed
ad verbatim.
As with the QRI qualitative data analysis, interviews
will be analysed thematically.
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Plans to give access to the full protocol, participant level-
data and statistical code
The full protocol is available via clinicaltrials.gov
(https://clinicaltrials.gov/ct2/show/NCT04027205). In
the first instance, further requests for data can be made
via the corresponding author.
Oversight and monitoring
Composition of the coordinating centre and trial steering
committee
The chief investigator (CL) is responsible for the con-
duct of the study and will be supported by the TMG
comprising members of the research team.
An independent TSC will oversee the study and in-
cludes an independent chair and four further independ-
ent members comprising a statistician, lay and clinical
representatives. The CI, senior statistician and Trial
Manager will attend the TSC meetings and present and
report progress. TSC meetings will be scheduled ap-
proximately annually.
Composition of the data monitoring committee, its role and
reporting structure
Since this is a pilot RCT with no planned interim statis-
tical analysis, a Data Monitoring Committee has not
been formed and the TSC has agreed to take responsibil-
ity for reviewing the safety of the trial including advice
regarding progression to a main RCT with reference to
the pre-specified progression criteria.
Adverse event reporting and harms
Number and type of adverse events for up to 6 months
post-randomisation will be collected via patient self-
report questionnaire or telephone MDC at 3 and 6
months and via surgeon, physiotherapist or GP report.
Frequency and plans for auditing trial conduct
Independent TSC meetings will be scheduled approxi-
mately annually.
Plans for communicating important protocol amendments
to relevant parties (e.g. trial participants, ethical
committees)
Funders, sponsors and NHS Research & Development
Offices will be notified routinely and appropriate ap-
provals gained and communicated as required by them
and by the study sponsor.
Dissemination plans
The results of the SPeEDy study will be published in
peer-reviewed journals, presented at relevant confer-
ences and disseminated to clinicians and patients, as
appropriate.
Discussion
Despite a dearth of research evidence and uncertainty re-
garding the most clinical and cost-effective treatment in-
terventions for patients with traumatic rotator cuff tears,
current national guidelines suggest that people with sus-
pected traumatic tears should seek urgent surgical opinion
[8]. It remains unclear whether such an approach should
be recommended in preference to, for example, non-
surgical assessment and management. Recognising current
uncertainties, SPeEDy has been developed as a pilot and
feasibility RCT with integrated QRI and further qualitative
interviews to investigate the barriers, and facilitators, to
recruitment, intervention delivery and fidelity, and clinical
equipoise from the perspectives of patients and clinicians.
We expect recruitment to be challenging but there is a
clear need for a high-quality, fully powered, RCT to com-
pare surgery and usual post-operative rehabilitation versus
a programme of physiotherapist-led exercise for a defined
group of patients presenting with traumatic rotator cuff
tears. This pilot and feasibility RCT will determine the
feasibility of a fully powered RCT, including whether it is
possible to recruit patients and retain participants in their
allocated group.
Study status
The SPeEDy study (protocol version 1.0 dated 05 August
2019) opened to recruitment on 3 March 2020, and was
scheduled to complete recruitment by 31 January 2021.
However, recruitment was paused due to COVID-19 on
16 March 2020, re-opened on 3 August 2020, but then
paused again on 4 October 2020, to enable transfer of
the study sponsor.
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